[go: up one dir, main page]

HN1997000124A - Lineas de celulas inmortalizadas para el desarrollo del virus. - Google Patents

Lineas de celulas inmortalizadas para el desarrollo del virus.

Info

Publication number
HN1997000124A
HN1997000124A HN1997000124A HN1997000124A HN1997000124A HN 1997000124 A HN1997000124 A HN 1997000124A HN 1997000124 A HN1997000124 A HN 1997000124A HN 1997000124 A HN1997000124 A HN 1997000124A HN 1997000124 A HN1997000124 A HN 1997000124A
Authority
HN
Honduras
Prior art keywords
cell lines
viruses
development
immortalized cell
production
Prior art date
Application number
HN1997000124A
Other languages
English (en)
Inventor
Douglas N Foster
Linda K Foster
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of HN1997000124A publication Critical patent/HN1997000124A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Esta invención se refiere a la producción y el uso de líneas de células inmortalizadas de fibroblastos embrionarios primarios de pollo. Las células son útiles como sustratos para la propagación de virus, expresión de la proteína recombinante y la producción de virus recombinante.
HN1997000124A 1996-08-13 1997-08-26 Lineas de celulas inmortalizadas para el desarrollo del virus. HN1997000124A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth

Publications (1)

Publication Number Publication Date
HN1997000124A true HN1997000124A (es) 1999-03-19

Family

ID=24796108

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000124A HN1997000124A (es) 1996-08-13 1997-08-26 Lineas de celulas inmortalizadas para el desarrollo del virus.

Country Status (28)

Country Link
US (4) US5672485A (es)
EP (1) EP0920491B1 (es)
JP (3) JP3754088B2 (es)
KR (1) KR100375871B1 (es)
CN (1) CN1228119B (es)
AR (1) AR008294A1 (es)
AT (1) ATE362524T1 (es)
AU (1) AU726820B2 (es)
BR (1) BR9711067A (es)
CA (1) CA2263725C (es)
CO (1) CO4700552A1 (es)
DE (1) DE69737735T2 (es)
DK (1) DK0920491T3 (es)
DZ (1) DZ2291A1 (es)
ES (1) ES2285738T3 (es)
GT (1) GT199700091A (es)
HN (1) HN1997000124A (es)
HU (1) HU226658B1 (es)
IL (4) IL158302A0 (es)
MA (1) MA24303A1 (es)
MY (1) MY125594A (es)
NZ (1) NZ334147A (es)
PE (1) PE108198A1 (es)
PT (1) PT920491E (es)
SV (1) SV1997000071A (es)
UY (1) UY24668A1 (es)
WO (1) WO1998006824A1 (es)
ZA (1) ZA977216B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) * 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040210954A1 (en) * 2003-03-07 2004-10-21 Alex Harvey Integrase mediated avian transgenesis
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
AU2003254860A1 (en) * 2002-09-30 2004-04-23 Honda Giken Kogyo Kabushiki Kaisha Hydrogen activating apparatus
US20040170646A1 (en) * 2002-12-13 2004-09-02 Aventis Pasteur, Inc. Production of ALVAC on avian embryonic stem cells
EP1599573B1 (en) * 2003-02-17 2013-06-19 Cold Spring Harbor Laboratory Model for studying the role of genes in tumor resistance to chemotherapy
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
CA2531565C (en) 2003-07-22 2014-02-11 Vivalis Production of poxviruses with adherent or non adherent avian cell lines
WO2005028634A2 (en) * 2003-09-18 2005-03-31 Emory University Improved mva vaccines
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
US20070190601A1 (en) * 2004-10-08 2007-08-16 Avigenics, Inc. Modified integrase and methods of use
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
EP1896587A2 (en) 2005-05-31 2008-03-12 Cold Spring Harbor Laboratory METHODS FOR PRODUCING MICRORNAs
EP1931698B1 (en) * 2005-10-05 2019-05-29 Alexion Pharmaceuticals, Inc. Rapid production of high titer virus
ES2671230T3 (es) 2006-06-20 2018-06-05 Transgene Sa Procedimiento para producir poxvirus y composiciones de poxvirus
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (en) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
RU2475536C2 (ru) * 2007-07-03 2013-02-20 Трансген С.А. Иммортализованная клеточная линия птиц
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
US8901288B2 (en) * 2007-10-26 2014-12-02 Cold Spring Harbor Laboratory High throughput methods for functionally determining RNA interference efficiency
CA2715719C (en) 2008-02-25 2019-08-06 Baxter International Inc. Method for producing continuous cell lines
BRPI1007743A2 (pt) 2009-05-12 2017-09-19 Transgene Sa Linhagens de célula aviária imortalizada, usos de uma linhagem de célula aviária imortalizada, métodos para a produção de vírus e métodos para a produção de proteína
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
WO2012010280A1 (en) 2010-07-20 2012-01-26 Bavarian Nordic A/S Method for harvesting expression products
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
DK3226894T3 (da) 2014-12-01 2019-10-21 Transgene Sa Stabile flydende vacciniavirus-formuleringer
EP3227433B1 (en) 2014-12-04 2018-10-10 Intervet International B.V. Immortalised chicken embryo fibroblasts
US20180028626A1 (en) 2015-02-13 2018-02-01 Transgene Sa Immunotherapeutic vaccine and antibody combination therapy
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
US20190134190A1 (en) 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand
IL291373B2 (en) * 2016-07-11 2023-10-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Methods and systems for growing cells in culture
WO2018069316A2 (en) 2016-10-10 2018-04-19 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
US20200179507A1 (en) 2016-11-17 2020-06-11 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
US11306292B2 (en) 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
US11052147B2 (en) 2017-05-15 2021-07-06 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR20240113607A (ko) 2017-06-21 2024-07-22 트랜스진 개인 맞춤형 백신
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
WO2020049151A1 (en) 2018-09-06 2020-03-12 Bavarian Nordic A/S Storage improved poxvirus compositions
US12478571B2 (en) 2018-12-17 2025-11-25 Pontis Biologics, Inc. Enzyme based compositions and methods for removing dental calculi
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
IL296250A (en) 2020-03-12 2022-11-01 Bavarian Nordic As Compositions improving poxvirus stability
US20230256057A1 (en) 2020-07-13 2023-08-17 Transgene Treatment of immune depression
MX2023002674A (es) 2020-09-07 2023-04-03 Intervet Int Bv Vacuna del tallo de ha para blancos positivos a anticuerpos ha.
CN116648259A (zh) 2020-12-24 2023-08-25 英特维特国际股份有限公司 多价hvt载体疫苗
CN117881422A (zh) 2021-07-13 2024-04-12 英特维特国际股份有限公司 克服禽类中的抗体干扰
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
EP4518893A1 (en) 2022-05-05 2025-03-12 Intervet International B.V. New multivalent hvt vector vaccine
WO2025074921A1 (ja) * 2023-10-06 2025-04-10 株式会社微生物化学研究所 ウイルスの生産方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
IL128511A0 (en) 2000-01-31
US5879924A (en) 1999-03-09
AU726820B2 (en) 2000-11-23
GT199700091A (es) 1997-08-12
NZ334147A (en) 2000-08-25
US6207415B1 (en) 2001-03-27
CN1228119B (zh) 2012-04-04
CO4700552A1 (es) 1998-12-29
MA24303A1 (fr) 1998-04-01
HK1022496A1 (en) 2000-08-11
DE69737735D1 (de) 2007-06-28
IL158302A0 (en) 2004-05-12
JP3754088B2 (ja) 2006-03-08
IL128511A (en) 2004-06-01
HUP0000188A3 (en) 2005-11-28
KR100375871B1 (ko) 2003-03-10
US5672485A (en) 1997-09-30
PE108198A1 (es) 1999-01-21
EP0920491B1 (en) 2007-05-16
BR9711067A (pt) 1999-08-17
KR20000029968A (ko) 2000-05-25
US5985642A (en) 1999-11-16
MY125594A (en) 2006-08-30
IL158301A0 (en) 2004-05-12
ES2285738T3 (es) 2007-11-16
EP0920491A1 (en) 1999-06-09
WO1998006824A1 (en) 1998-02-19
DK0920491T3 (da) 2007-09-17
HU226658B1 (en) 2009-06-29
ATE362524T1 (de) 2007-06-15
AU4069197A (en) 1998-03-06
DZ2291A1 (fr) 2002-12-25
CA2263725C (en) 2002-10-15
HUP0000188A2 (hu) 2000-06-28
AR008294A1 (es) 1999-12-29
CA2263725A1 (en) 1998-02-19
ZA977216B (en) 1998-02-19
JP2005118053A (ja) 2005-05-12
PT920491E (pt) 2007-07-27
JP2006320328A (ja) 2006-11-30
UY24668A1 (es) 1998-02-02
IL158303A0 (en) 2004-05-12
DE69737735T2 (de) 2008-01-31
JP2000516095A (ja) 2000-12-05
SV1997000071A (es) 2000-07-06
CN1228119A (zh) 1999-09-08

Similar Documents

Publication Publication Date Title
HN1997000124A (es) Lineas de celulas inmortalizadas para el desarrollo del virus.
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
CY1105772T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια
AR024318A1 (es) Moleculas de acido nucleico del trigo, celulas de plantas transgenicas y plantas y el uso de las mismas para la produccion de almidon modificado.
ATE263841T1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
ATE268378T1 (de) Humane epithelzellinien der leber
ES2147720T3 (es) Factor de celulas madre.
ES2122145T3 (es) Fosfiniloximetil-cetonas peptidicas como inhibidores de la enzima convertida de la interleuquina-1 beta.
TR200000073T2 (tr) 5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
CO5580844A2 (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
NO981430L (no) Avkortet gliacellelinjeavledet neurotrof faktor
ES2193192T3 (es) Receptores de interleuquina-15.
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
FR2749022B1 (fr) Cellules aviaires immortelles
MXPA04001720A (es) Acido nucleicos bv8 y polipeptidos con actividad mitogenica.
CA2263790A1 (en) Method for immortalizing cells
DK0901523T3 (da) Udödeliggjorte fuglecellelinjer
ES2175246T3 (es) Reticulante pobre en reversion.
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
ECSP972224A (es) Celulas inmortalizadas para cultivo de virus
DK1059931T3 (da) Anvendelse af CD137 til fremme af perifere monocytters proliferation
CO4790179A1 (es) Procedimiento para la fabricacion de proteinas humanas por activacion genica endogena